leadf
logo-loader
viewPembridge Resources PLC

Pembridge Resources surges as it unveils £633,000 premium fundraising

Pembridge also said it has agreed to alter the terms of a convertible loan agreement with its chairman and chief executive Gati Al-Jebouri

Pembridge Resources PLC - Pembridge Resources surges as it unveils £633,000 premium fundraising

Pembridge Resources PLC (LON:PERE) has raised £633,000 in a premium share subscription to bolster its equity capital during the coronavirus pandemic.

The company said it had raised the funds through the subscription of around 19.2mln new shares at a price of 3.3p each, a 20% premium to its closing price last Friday.

READ: Pembridge Resources CEO voluntarily reduces salary by 50%

Pembridge also said it has agreed to alter the terms of a convertible loan agreement with its chairman and chief executive Gati Al-Jebouri, to extend the maturity date on the loans to 31 December 2022 from 25 October 2021, increases the interest rate to 10% from 8% and remove the right of Al-Jebouri to convert any of the loans to shares in the company.

"This additional equity capital will strengthen the company and reduce the requirement to draw down further on the convertible loan. Moreover, the subscription at a premium to the market price highlights the continued confidence of the Board and some of its largest shareholders in the company”, the CEO said.

“We believe that we can rebuild shareholder value from these depressed levels, especially given we have now strengthened the financial condition of the company”, Al-Jebouri added.

Shares in Pembridge surged 17.8% to 3.2p in lunchtime trading on Monday.

Quick facts: Pembridge Resources PLC

Price: 3.75 GBX

LSE:PERE
Market: LSE
Market Cap: £2.79 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pembridge Resources PLC named herein, including the promotion by the Company of Pembridge Resources PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Canntab Therapeutics achieves major milestone receiving first U.S. patent...

Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CEO Larry Latowsky joined Steve Darling from Proactive Vancouver with news the company has secured protection for their intellectual property receiving a U.S. patent for “Modified Release Multi-Layer Tablet Cannabinoid Formulations.” Latowsky...

11 hours, 7 minutes ago

2 min read